Rothschild Investment LLC Has $1.19 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Rothschild Investment LLC lowered its stake in shares of Danaher Co. (NYSE:DHR) by 5.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,160 shares of the conglomerate’s stock after selling 287 shares during the period. Rothschild Investment LLC’s holdings in Danaher were worth $1,185,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in DHR. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the fourth quarter worth about $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher during the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher in the fourth quarter worth approximately $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher in the fourth quarter worth approximately $31,000. Finally, Pineridge Advisors LLC lifted its holdings in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Stock Up 0.5 %

Shares of NYSE DHR opened at $211.23 on Tuesday. The firm has a fifty day simple moving average of $226.25 and a two-hundred day simple moving average of $246.44. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $150.97 billion, a PE ratio of 40.01, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the company earned $2.09 earnings per share. Equities analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. Danaher’s dividend payout ratio is 24.24%.

Analyst Ratings Changes

A number of research firms recently commented on DHR. JPMorgan Chase & Co. lowered their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Citigroup lowered their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a report on Thursday, January 30th. Wells Fargo & Company cut their price target on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. The Goldman Sachs Group set a $250.00 price objective on shares of Danaher in a research note on Wednesday, January 15th. Finally, StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.